Pavel Andreevich Chizhkov

Pavel Andreevich Chizhkov

Auto-generated profile, based on publicly available information

Pavel Andreevich Chizhkov

Department of Genetics, Cytology and Bioengineering, Voronezh State University, 394018 Voronezh, Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
IBInna Burakova
Inna Burakova
YDYuliya Dmitrievna Dvoretskaya
Yuliya Dmitrievna Dvoretskaya
MGMariya Vladimirovna Gryaznova
Mariya Vladimirovna Gryaznova
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
PCPavel Chizhkov
Pavel Chizhkov
Vasily N. PopovVasily N. Popov
Vasily N. Popov
Obesity is a problem of modern health care that causes the occurrence of many concomitant diseases: arterial hypertension, diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. New strategies for the treatment and prevention of obesity are being developed that are based on using probiotics for modulation of the gut microbiota. Our study aimed to evaluate the bacterial composition of the gut of obese patients before and after two weeks of lactic acid bacteria (Lactobacillus acidophilus, Lactiplantibacillus plantarum, Limosilactobacillus fermentum, and Lactobacillus delbrueckii) intake. The results obtained showed an increase in the number of members of the phylum Actinobacteriota in the group taking nutritional supplements, while the number of phylum Bacteroidota decreased in comparison with the control group. There has also been an increase in potentially beneficial groups: Bifidobacterium, Blautia, Eubacterium, Anaerostipes, Lactococcus, Lachnospiraceae ND3007, Streptococcus, Escherichia-Shigella, and Lachnoclostridium. Along with this, a decrease in the genera was demonstrated: Faecalibacterium, Pseudobutyrivibrio, Subdoligranulum, Faecalibacterium, Clostridium sensu stricto 1 and 2, Catenibacterium, Megasphaera, Phascolarctobacterium, and the Oscillospiraceae NK4A214 group, which contribute to the development of various metabolic disorders. Modulation of the gut microbiota by lactic acid bacteria may be one of the ways to treat obesity.

12 July 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MGMariya Vladimirovna Gryaznova
Mariya Vladimirovna Gryaznova
YDYuliya Dmitrievna Dvoretskaya
Yuliya Dmitrievna Dvoretskaya
IBInna Burakova
Inna Burakova
PMPolina Morozova
Polina Morozova
SLSvetlana Lagutina
Svetlana Lagutina
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
Background: Irritable bowel syndrome (IBS) is a common condition that affects the lifestyle of patients. It is associated with significant changes in the composition of the gut microbiome, but the underlying microbial mechanisms remain to be fully understood. We study the fecal microbiome of patients with constipation-predominant IBS (IBS-C) and mixed-type IBS (IBS-M). Methods: We sequenced the V3 region of the 16S rRNA on the Ion Torrent PGM sequencing platform to study the microbiome. Results: In the patients with IBS-C and IBS-M, an increase in alpha diversity was found, compared to the healthy group, and differences in beta diversity were also noted. At the phylum level, both IBS subtypes showed an increase in the Firmicutes/Bacteroidetes ratio, as well as an increase in the abundance of Actinobacteria and Verrucomicrobiota. Changes in some types of bacteria were characteristic of only one of the IBS subtypes, while no statistically significant differences in the composition of the microbiome were detected between IBS-C and IBS-M. Conclusions: This study was the first to demonstrate the association of Turicibacter sanguinis, Mitsuokella jalaludinii, Erysipelotrichaceae UCG-003, Senegalimassilia anaerobia, Corynebacterium jeikeium, Bacteroides faecichinchillae, Leuconostoc carnosum, and Parabacteroides merdae with IBS subtypes.

26 June 2023 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
MGMariya Vladimirovna Gryaznova
Mariya Vladimirovna Gryaznova
YDYuliya Dmitrievna Dvoretskaya
Yuliya Dmitrievna Dvoretskaya
IBInna Burakova
Inna Burakova
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
PCPavel Chizhkov
Pavel Chizhkov
Vasily N. PopovVasily N. Popov
Vasily N. Popov

30 June 2023 in Juvenis scientia
Verified
Journal Article
Open access
PDF file
SLSvetlana Lagutina
Svetlana Lagutina
PCP. A. Chizhkov
P. A. Chizhkov
АЗА.а. Зуйкова
А.а. Зуйкова
EEE. Yu. Esina
E. Yu. Esina
IDI. S. Dobrynina
I. S. Dobrynina
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
Введение. Воспалительные заболевания кишечника (ВЗК) занимают лидирующие позиции в структуре заболеваний желудочно-­кишечного тракта (ЖКТ), так как являются прогрессирующей хронической патологией с аутоиммунным типом воспаления. Изменение показателей микробиоты кишечника может определять морфологические изменения на латентном этапе заболевания. Цель исследования. Оценка родо-видового биоразнообразия микробиоты у пациентов с ВЗК. Пациенты и методы. Выполнено секвенирование 16S рРНК микробиоты кишечника у 15 пациентов с подтвержденным язвенным колитом (ЯК) и 20 здоровых лиц, которые являлись контрольной группой. Проведен анализ показателей общего анализа крови и уровня С-реактивного белка (СРБ). Для статистического анализа использовали программы Microsoft Excel и Statistica. Результаты. Среди исследуемых лабораторных показателей у пациентов с ВЗК было отмечено значительное увеличение уровня СРБ, лейкоцитов и нейтрофилов по сравнению с группой контроля. В результате секвенирования кишечной микробиоты у пациентов с ВЗК выявлено снижение нормобиоты, а также увеличение содержания представителей патогенного кластера. Заключение. Выявлено снижение биоразнообразия микробиоты у пациентов с ВЗК по сравнению с группой контроля. Также наблюдалось значимое изменение патогенного кластера и дисбаланс представителей Bacteroidetes и Firmicutes. Introduction. Inflammatory bowel diseases (IBD) occupy a leading position in the structure of diseases of the gastrointestinal tract (GIT), as they are a progressive chronic pathology with an autoimmune type of inflammation. Changes in the composition of the gut microbiota can determine morphological changes at the latent stage of the disease. Aim of the study. To assess the genus-­species biodiversity of the microbiota in patients with IBD. Patients and methods. 16S rRNA sequencing of the intestinal microbiota was performed in 15 patients with confirmed ulcerative colitis (UC) and 20 healthy controls. The parameters of the full blood count and the serum level of C-reactive protein (CRP) were analyzed. The analysis of the obtained data was carried out using Microsoft Excel and Statistica software. Results. Among the studied laboratory parameters in patients with IBD, there was a significant increase in CRP, leukocyte and neutrophil counts compared to the control group. Sequencing of the gut microbiota showed a decrease in the normobiota, as well as an increase in the representatives of the pathogenic cluster. Conclusion. In the present study, we demonstrated a decrease in the biodiversity of the gut microbiota in patients with IBD compared to the control group, a significant change in the pathogenic cluster, and an imbalance between the representatives of Bacteroidetes and Firmicutes.

26 October 2022 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
SLSvetlana Lagutina
Svetlana Lagutina
AZAnna Alexsandrovna Zuikova
Anna Alexsandrovna Zuikova
IDIrina Sergeevna Dobrynina
Irina Sergeevna Dobrynina
PCPavel Andreevich Chizhkov
Pavel Andreevich Chizhkov
OSOlga Sergeevna Skuratova
Olga Sergeevna Skuratova
Background: Currently, there is an increase in cancer among the elderly. Despite the obvious advances in the healthcare related to the diagnosis of the disease and its treatment, oncopathology occupies a high position in the structure of the overall morbidity. Clinical case description: Patient T., 62 years old, came to an internist with the complaints of constant pulling pains in the lower abdomen, a stool disorder in the form of alternating constipation and diarrhea, presence of blood in the stool over the past 6 months, a weight loss of 8 kg over the past 4 months. She was examined independently two years ago, when the disorders of the gastrointestinal tract appeared for the first time, which she associated with constant stressful situations at work. According to the study results, no significant deviations were found. The patient also underwent 16s-RNA sequencing of the intestinal microbiome, which revealed significant changes in many clusters of bacteria (a decrease in the quantitative composition of Lactobacterium, Bifidobacterium, Akkermansia, Faecalibacterium, which is the main representative of the normal intestinal flora, that may indicate a decrease in the protective barrier function of the colonic mucosa, an increase in Fusobacterium, as well as other representatives of the pathogenic flora). Presently, within the framework of laboratory and instrumental studies, the following diagnosis was established: "Malignant formation of the colon (colorectal cancer). T3M0N1". A repeated study of the intestinal microbiota was carried out, according to the results of which an increase in Fusobacterium up to 7.5% was observed, along with a sharp decrease in the representatives of the normoflora (1%). Conclusion: Changes in various bacterial clusters of the intestinal microbiota can serve as an early marker for the verification of malignant neoplasms of the large intestine. Determining the amount of Fusobacterium in the intestinal microbiome can be an indicator of the first diagnostic line, which helps to identify the pathological process at the stage of precancer, take timely therapeutic measures, improve the quality of life, and increase its longevity.

25 October 2023 in Therapy
Verified
Journal Article
Closed access
SLSvetlana Lagutina
Svetlana Lagutina
CCChizhkov P.A. Chizhkov
Chizhkov P.A. Chizhkov
ZZZuykova A.A. Zuykova
Zuykova A.A. Zuykova
DDDobrynina I.S. Dobrynina
Dobrynina I.S. Dobrynina
Vasily N. PopovVasily N. Popov
Vasily N. Popov
VUVoronezh State University
Voronezh State University